Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

16 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Follow-Up - Brain Cancer - Event Monitoring Form - 2287724v3.0 - Brain Cancer - Event Monitoring Form

- 9/1/15 - 1 formulario, 7 itemgroups, 29 items, 1 idioma
Itemgroups: CRF Header, Brain: Vital Status, Brain: Off Study Reason, Brain: Disease Follow-Up Status, Brain: Notice of Progression, Brain: Notice of New Primary, Brain: Long-Term Toxicity
Brain Cancer - Event Monitoring Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E51DD029-A8BB-3E76-E034-0003BA3F9857

Recurring cancer children (ADVL0212 NCT00053963) - Reporting Period Worksheet cancer (NCT00053963)

- 22/3/15 - 1 formulario, 5 itemgroups, 58 items, 1 idioma
Itemgroups: Header, Patient characteristics, Concomitant Medication, Patient status, Adverse event
ADVL0212: Reporting Period Worksheet FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia NCT00053963 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1EC15B1-1989-311F-E034-0003BA12F5E7

Follow-Up - Follow-Up Brain Tumor Evaluation Form - 2290890v3.0 - Follow-Up Brain Tumor Evaluation Form

- 9/1/15 - 1 formulario, 8 itemgroups, 44 items, 1 idioma
Itemgroups: CRF Header, Brain: Follow-up Form Administration, Brain: Baseline Status, Brain: Measurable Lesion(s) Follow-up Evaluation, Brain: Non-measureable/evaluable Lesion(s) Follow-up Evaluation, Brain: New Lesion(s) at Follow-up Evaluation, Brain: Evaluation Summary, Comments
Follow-Up Brain Tumor Evaluation Form Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E12EA69C-FEB7-54BA-E034-0003BA12F5E7

Lapatinib + Topotecan or + Capecitabine in Recurrent Brain Metastases from Breast Cancer; NCT00437073 - Survival Follow-Up

- 13/10/20 - 1 formulario, 2 itemgroups, 5 items, 1 idioma
Itemgroups: Date of visit, Assessment Date, follow-up, Continuance of life
Study ID: 107671 Clinical Study ID: 107671 Study Title: EGF107671 – A Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00437073 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: N/A Trade Name: capecitabine, topotecan, lapatinib Study Indication: Neoplasms, Breast; Recurrent Brain Metastases

ACNS0122 Follow-up Worksheet NCT00047320

- 16/6/15 - 1 formulario, 6 itemgroups, 29 items, 1 idioma
Itemgroups: Header, FOLLOW-UP STUDIES, DISEASE STATUS, EVALUATIONS, SIGNIFICANT EVENTS DURING THIS REPORTING PERIOD, CCRR MODULE
ACNS0122 Follow-up Worksheet NCT00047320 Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BD7AAA29-31DD-2A8B-E034-0003BA12F5E7

Brain and Central Nervous System Tumors NCT00978458 Follow-Up - E3F05 Long-Term Follow-up Form - 2900961v1.0 - E3F05 Long-Term Follow-up Form

- 8/1/15 - 1 formulario, 9 itemgroups, 34 items, 1 idioma
Itemgroups: Header Module, Header, Section I - Vital Status, Section II - Reporting Period, Section III - Notice of New Primary, Section IV - Disease Follow-up Status, Section V - Adverse Events, Section VI - Non-Protocol Therapy Prior To (CNS) Progression, Footer Module
E3F05 Long-Term Follow-up Form Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6C1889F9-D142-5474-E040-BB89AD431A23

RTOG-0525 F1: Follow-Up Form NCT00304031

- 16/6/15 - 1 formulario, 6 itemgroups, 45 items, 1 idioma
Itemgroups: Clinical trial administrative data, Assessment, Disease Progression, Non-Protocol Therapy, Non-Protocol Therapy To Brain, Footer
RTOG-0525 F1: Follow-Up Form NCT00304031 Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FD9AAA90-325E-6D58-E034-0003BA3F9857

Brain and Central Nervous System Tumors NCT00978458 Follow-Up - E3F05 Primary Brain Tumor Follow-Up Disease Evaluation Form - 2902962v1.0 - E3F05 Primary Brain Tumor Follow-Up Disease Evaluation Form

- 8/1/15 - 1 formulario, 16 itemgroups, 94 items, 1 idioma
Itemgroups: Header Module, Header, ON TREATMENT, OFF TREATMENT, Section I, Section II MEASURABLE LESIONS, T2/FLAIR, T1/Contrast, Section III - Lesions Reported as Non-Measurable at Baseline, T2/FLAIR , T1/Contrast, Section IV New CNS Lesions/New Enhancement of Previously Reported Lesions, T2/FLAIR, T1/Contrast, Section V Progression, Comments
E3F05 Primary Brain Tumor Follow-Up Disease Evaluation Form Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6CB91C46-8BDC-9A0D-E040-BB89AD433170

RTOG 0825 Phase III GBM Follow-Up Form (F1) NCT00884741

- 8/7/15 - 1 formulario, 7 itemgroups, 65 items, 1 idioma
Itemgroups: RTOG clinical trial administrative data, Patient status assessment, RECURRENCE OR PROGRESSION, Non-Protocol Therapy, Protocol Specific Adverse Event Evaluation1, Protocol Specific Adverse Event Evaluation2, Comments
RTOG 0825 Phase III GBM Follow-Up Form (F1) NCT00884741 Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5A7D0D0E-5E03-3FE7-E044-0003BA3F9857

Brain and Central Nervous System Tumors NCT00887146 Follow-Up - North Central Cancer Treatment Group N0577 - Patient Questionnaire Booklet Compliance Form - 2745216v1.0 - North Central Cancer Treatment Group N0577 - Patient Questionnaire Booklet Compliance Form

- 9/1/15 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Header, Header
North Central Cancer Treatment Group N0577 - Patient Questionnaire Booklet Compliance Form Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C07E8C3-3298-293D-E044-0003BA3F9857

Brain and Central Nervous System Tumors NCT00053963 Off Treatment - Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212] - 2077867v3.0 - Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212]

- 9/1/15 - 1 formulario, 4 itemgroups, 28 items, 1 idioma
Itemgroups: Header, Patient Status Information, Events of Interest, CCRR MODULE
Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212] FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B24316ED-D5DA-16A3-E034-0003BA12F5E7

ADVL0212: Secondary Malignancy Report Worksheet NCT00053963

- 5/7/15 - 1 formulario, 3 itemgroups, 12 items, 1 idioma
Itemgroups: Header, Secondary Malignancy, CCRR MODULE
ADVL0212: Secondary Malignancy Report Worksheet NCT00053963 FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1EADE06-A88A-30BB-E034-0003BA12F5E7

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial